Source: Virtual Congress 2021 – Bronchiectasis



Rating:

Share or cite this content

Citations should be made in the following way:
M. Shteinberg (Haifa, Israel), E. Polverino (Barcelona, Spain), P. Burgel (Paris, France), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valencia, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De Soyza (Newcastle, Germany), M. Vendrell (Girona, Spain), A. Shoemark (Dundee, United Kingdom), J. Altenburg (Amsterdam, Netherlands), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), S. Elborn (Belfast, United Kingdom), S. Aliberti (Milan, Italy), P. Goeminne (Sint Niklaas, Belgium). The prevalence and impact of autoantibodies among people with bronchiectasis: a data analysis of the EMBARC registry. 2059

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and characteristics of self-reported hypothyroidism and its association with nonorgan-specific manifestations in US sarcoidosis patients: a nationwide registry study Source: ERJ Open Res, 7 (1) 00754-2020; 10.1183/23120541.00754-2020 Year: 2021 Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care Source: Annual Congress 2009 - Risk factors for COPD Year: 2009 Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study Source: Eur Respir J, 58 (3) 2002288; 10.1183/13993003.02288-2020 Year: 2021 The heterogeneity of bronchiectasis patient characteristics, management and outcomes across Europe: Data from the EMBARC registry Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 The presence and impact of chronic kidney disease in COPD patients, data from the German COSYCONET cohort Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 The effect of sex and age on the comorbidity burden of OSA: an observational analysis from a large nationwide US health claims database Source: Eur Respir J 2016; 47: 1162-1169 Year: 2016 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 The prevalence of diagnosed ?1-antitrypsin deficiency and its comorbidities: results from a large population-based database Source: Eur Respir J 2017; 49(1): 1600154; DOI: 10.1183/13993003.00154-2016 Year: 2017 Sex related differences in aetiology, severity and quality of life in bronchiectasis: data from the EMBARC, EMBARC-India and Australian bronchiectasis registries Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Patient burden of not well-controlled asthma: results of a European survey Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care Year: 2009 Psychiatric disorders in patients with COPD: a population-based study on prevalence and the relationship with smoking Source: Eur Respir J 2001; 18: Suppl. 33, 192s Year: 2001 Deteriorating heath status in bronchiectasis : longitudinal data from the EMBARC registry Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes Year: 2021 COPD prevalence data derived from a health screening clinic – less bias than expected Source: Eur Respir J 2006; 28: Suppl. 50, 741s Year: 2006 Clinical characteristics, mortality rates and causes of death in non-exacerbating COPD patients. A longitudinal cohort analysis of UK primary care data. Source: Virtual Congress 2021 – New evidence from longitudinal COPD cohorts and other key studies Year: 2021 Population-based analysis of COPD patients in Catalonia: implications for case management Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017 Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR) Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021 Validity of COPD diagnosis in Bronchiectasis patients: data from the EMBARC registry Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM) Year: 2018 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015